Download PDF
Semin Plast Surg 2006; 20(4): 249-255
DOI: 10.1055/s-2006-951583
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Postoperative Nausea and Vomiting in Plastic Surgery

Donald W. Buck1  II , Thomas A. Mustoe1 , John Y.S Kim1
  • 1Division of Plastic and Reconstructive Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
Further Information

Publication History

Publication Date:
18 October 2006 (online)

    Permissions and Reprints

ABSTRACT

Postoperative nausea and vomiting (PONV) is a common problem affecting nearly one third of all surgical patients. In addition to making the patient feel miserable, PONV is a major cause of prolonged recovery, unintended hospital admission, and poor patient satisfaction after surgery. Retching and vomiting can also lead to hematoma formation, wound and suture dehiscence, and aspiration. Thus, the prevention of PONV is an important goal in the overall outcome of surgery and, in particular, plastic surgery. The etiology of PONV is multifactorial, and several important risk factors have been identified. These factors include female gender, nonsmoking status, and a history of PONV or opioid-induced nausea and emesis. Volatile anesthetics and long operative duration also increase the risk of PONV. Reduction in the incidence of PONV requires careful assessment of patient-related risk factors as well as the appropriate use of prophylactic antiemetics. There are many antiemetic medications on the market today. Ondansetron, a serotonin 5-hydroxytryptamine antagonist, appears to be the current drug of choice for PONV prophylaxis. It has greatest efficacy and cost-effectiveness when used in patients at moderate to high risk. In addition, surgeons can consider using intravenous propofol or conscious sedation instead of general anesthesia where appropriate.

KEYWORDS

Postoperative - nausea - vomiting - emesis - PONV - antiemetic

REFERENCES

  • 1 Apfel C C, Korttila K, Abdalla M et al.. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.  N Engl J Med. 2004;  350 2441-2451
    CrossrefPubMedGoogle Scholar
  • 2 Marcus J R, Few J W, Chao J D, Fine N A, Mustoe T A. The prevention of emesis in plastic surgery: a randomized, prospective study.  Plast Reconstr Surg. 2002;  109 2487-2494
    CrossrefPubMedGoogle Scholar
  • 3 Hirsch J. Impact of postoperative nausea and vomiting in the surgical setting.  Anaesthesia. 1994;  49 30-33
    PubMedGoogle Scholar
  • 4 Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The prospective patients.  Anesth Analg. 1999;  89 652-658
    CrossrefPubMedGoogle Scholar
  • 5 Myles P S, Williams D L, Hendrata M et al.. Patient satisfaction after anesthesia and surgery: results of a prospective survey of 10811 patients.  Br J Anaesth. 2000;  84 6-10
    CrossrefPubMedGoogle Scholar
  • 6 Gan T, Sloan F, Dear G et al.. How much are patients willing to pay to avoid postoperative nausea and vomiting?.  Anesth Analg. 2001;  92 393-400
    CrossrefPubMedGoogle Scholar
  • 7 Marcus J R, Tyrone J W, Few J W, Fine N A, Mustoe T A. Optimization of conscious sedation in plastic surgery.  Plast Reconstr Surg. 1999;  104 1338-1345
    PubMedGoogle Scholar
  • 8 Dingman R O. Severe bleeding during and after face-lifting operations under general anesthesia.  Plast Reconstr Surg. 1972;  50 608
    PubMedGoogle Scholar
  • 9 Thompson D P, Ashley F L. Face-lift complications: a study of 922 cases performed in a 6-year period.  Plast Reconstr Surg. 1978;  61 40-49
    PubMedGoogle Scholar
  • 10 Steely R L, Collins D R, Cohen B E, Bass K. Postoperative nausea and vomiting in the plastic surgery patient.  Aesthetic Plast Surg. 2004;  28 29-32
    PubMedGoogle Scholar
  • 11 Williams K S. Postoperative nausea and vomiting.  Surg Clin North Am. 2005;  85 1229-1241
    PubMedGoogle Scholar
  • 12 Watcha M F, White P F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention.  Anesthesiology. 1992;  77 162-184
    PubMedGoogle Scholar
  • 13 Tortorice P V, O'Connell M B. Management of chemotherapy-induced nausea and vomiting.  Pharmacotherapy. 1990;  10 129-145
    PubMedGoogle Scholar
  • 14 Stadler M, Bardiau F, Seidel L et al.. Difference in risk factors for postoperative nausea and vomiting.  Anethesiology. 2003;  98 46-52
    CrossrefPubMedGoogle Scholar
  • 15 Apfel C C, Roewer N. Risk assessment of postoperative nausea and vomiting.  Int Anesthesiol Clin. 2003;  41 13-32
    PubMedGoogle Scholar
  • 16 Cohen M M, Duncan P G, DeBoer D P et al.. The postoperative interview: assessing risk factors for nausea and vomiting.  Anesth Analg. 1994;  78 7-16
    PubMedGoogle Scholar
  • 17 Sadhasivam S, Shende D, Madan R. Prophylactic ondansetron in prevention of postoperative nausea and vomiting following pediatric strabismus surgery: a dose-response study.  Anesthesiology. 2000;  92 1035-1042
    PubMedGoogle Scholar
  • 18 Gurler T, Celik N, Totan S, Songur E, Sakarya M. Prophylactic use of ondansetron for emesis after craniofacial operations in children.  J Craniofac Surg. 1999;  10 45-48
    PubMedGoogle Scholar
  • 19 Rose J B, Watcha M F. Postoperative nausea and vomiting in paediatric patients.  Br J Anaesth. 1999;  83 104-117
    CrossrefPubMedGoogle Scholar
  • 20 Stubbs T K, Saylors S, Jenkins M et al.. Pediatric patients experiencing postoperative nausea and vomiting after burn reconstruction surgery: an analysis.  J Burn Care Rehabil. 1999;  20 236-238
    PubMedGoogle Scholar
  • 21 Apfel C C, Kranke P, Papenfufl T et al.. Volatile anaesthetics may be the main cause for early but not delayed postoperative nausea and vomiting: a randomized control trial of factorial design.  Br J Anaesth. 2002;  88 659-668
    CrossrefPubMedGoogle Scholar
  • 22 Unlugenc H, Guler T, Gunes Y, Isik G. Comparative study of the antiemetic efficacy of ondansetron, propofol, and midazolam in the early postoperative period.  Eur J Anaesthesiol. 2003;  20 668-673
    PubMedGoogle Scholar
  • 23 Hasen K V, Samartzis D, Casas L A, Mustoe T A. An outcome study comparing intravenous sedation with midazolam/fentanyl (conscious sedation) versus propofol infusion (deep sedation) for aesthetic surgery.  Plast Reconstr Surg. 2003;  112 1683-1689
    PubMedGoogle Scholar
  • 24 Watcha M F. The cost-effective management of postoperative nausea and vomiting [editorial; comment].  Anesthesiology. 2000;  92 931-933
    PubMedGoogle Scholar
  • 25 Apfel C C, Laara E, Koivuranta M, Greim C A, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting.  Anesthesiology. 1999;  91 693-700
    CrossrefPubMedGoogle Scholar
  • 26 Apfel C C, Kranke P, Eberhart J. Comparison of surgical site and patient's history with a simplified risk score for the prediction of postoperative nausea and vomiting.  Anaesthesia. 2004;  59 1078-1082
    CrossrefPubMedGoogle Scholar
  • 27 Tang J, Wang B, White P F et al.. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting.  Anesth Analg. 1998;  86 274-282
    PubMedGoogle Scholar
  • 28 Sadhasivam S, Saxena A, Kathirvel S et al.. The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy.  Anesth Analg. 1999;  89 1340-1345
    PubMedGoogle Scholar
  • 29 Gan T J, Meyer T, Apfel C C et al.. Consensus guidelines for managing postoperative nausea and vomiting.  Anesth Analg. 2003;  97 62-71
    PubMedGoogle Scholar
  • 30 Domino K B, Anderson E A, Polissar N L, Posner K L. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis.  Anesth Analg. 1999;  88 1370-1379
    CrossrefPubMedGoogle Scholar
  • 31 Dabbous A, Itani M, Kawas N et al.. Post-laparoscopic vomiting in females versus males: comparison of prophylactic antiemetic action of ondansetron versus metoclopramide.  JSLS. 1998;  2 273-276
    PubMedGoogle Scholar
  • 32 Malins A F, Field J M, Nesling P M, Coope G M. Nausea and vomiting after gynaecological laparoscopy: comparison of premedication with oral ondansetron, metoclopramide, and placebo.  Br J Anaesth. 1994;  72 231-233
    PubMedGoogle Scholar
  • 33 Paxton L D, McKay A C, Mirakhur R K. Prevention of nausea and vomiting after day case gynaecological laparoscopy: a comparison of ondansetron, droperidol, metoclopramide, and placebo.  Anaesthesia. 1995;  50 403-406
    PubMedGoogle Scholar
  • 34 Tang J, Watcha M F, White P F. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures.  Anesth Analg. 1996;  83 304-313
    PubMedGoogle Scholar
  • 35 Barbosa M VJ, Nahas F X, Ferreira L M et al.. Ondansetron for the prevention of postoperative nausea and vomiting: which is the best dosage for aesthetic plastic surgery.  Aesthetic Plast Surg. 2004;  28 33-36
    PubMedGoogle Scholar
  • 36 Sun R, Klein K W, White P F. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery.  Anesth Analg. 1997;  84 331-336
    CrossrefPubMedGoogle Scholar
  • 37 White P F, Hamza M A, Recart A et al.. Optimal timing of acustimulation for antiemetic prophylaxis as an adjunct to ondansetron in patients undergoing plastic surgery.  Anesth Analg. 2005;  100 367-372
    CrossrefPubMedGoogle Scholar
  • 38 Kovac A L. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists.  J Clin Anesth. 2006;  18 304-318
    CrossrefPubMedGoogle Scholar
  • 39 Cameron D, Gan T J. Management of postoperative nausea and vomiting in ambulatory surgery.  Anesthesiol Clin North Am. 2003;  21 347-365
    CrossrefPubMedGoogle Scholar
  • 40 Lim B S, Pavy T J, Lumsden G. The antiemetic and dysphoric effects of droperidol in the day surgery patient.  Anaesth Intensive Care. 1999;  27 371-374
    PubMedGoogle Scholar
  • 41 Tramer M R, Walder B. Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy.  Anesth Analg. 1999;  88 1354-1361
    CrossrefPubMedGoogle Scholar
  • 42 Tang J, Chen X, White P F et al.. Antiemetic prophylaxis for office-based surgery.  Anesthesiology. 2003;  98 293-298
    PubMedGoogle Scholar
  • 43 Habib A S, Gan T J. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.  J Clin Anesth. 2005;  17 62-65
    CrossrefPubMedGoogle Scholar
  • 44 Williams O A, Clarke F L, Harris R W et al.. Addition of droperidol to patient-controlled analgesia: effect on nausea and vomiting.  Anaesthesia. 1993;  48 881-884
    PubMedGoogle Scholar
  • 45 Approves F DA. EMEND® (aprepitant), Merck's Antiemetic Therapy, for the Prevention of Postoperative Nausea and Vomiting. Available at: http://www.emend.com/aprepitant/emend/hcp/ponv/index.jsp Accessed July 31, 2006
    Google Scholar
  • 46 American Society of Plastic Surgeons .Available at: http://www.plasticsurgery.org/new_room/press_releases/2004-Overall-Statistics.cfm Accessed July 15, 2006

John Y.S KimM.D. 

Associate Professor, Division of Plastic and Reconstructive Surgery, Northwestern University, Feinberg School of Medicine

675 North St. Clair Street, Suite 19-250, Chicago, IL 60611